Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience

Abstract Graft versus host disease (GVHD) is a severe complication after allogenic hematopoietic cell transplantation (HSCT). Several clinical trials have reported the use of mesenchymal stromal cells (MSCs) for the treatment of GVHD. In March 2008, the Andalusian Health Care System launched a compa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Stem cells translational medicine 2022-04, Vol.11 (4), p.343-355
Hauptverfasser:	Macías-Sánchez, María del Mar, Morata-Tarifa, Cynthia, Cuende, Natividad, Cardesa-Gil, Ana, Cuesta-Casas, María Ángeles, Pascual-Cascon, María Jesús, Pascual, Antonia, Martín-Calvo, Carmen, Jurado, Manuel, Perez-Simón, José Antonio, Espigado, Ildefonso, Garzón López, Sebastián, Carmona Sánchez, Gloria, Mata-Alcázar-Caballero, Rosario, Sánchez-Pernaute, Rosario
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Adolescent Adult Aged Child Compassionate Use Trials - adverse effects Female Graft vs Host Disease - etiology Graft vs Host Disease - therapy Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - methods Human Clinical Humans Male Mesenchymal Stem Cell Transplantation - adverse effects Mesenchymal Stem Cell Transplantation - methods Mesenchymal Stem Cells Middle Aged Steroids - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!